drugset / Trial / NCT01868802
Ketamine for Treatment-resistant Depression: A Multicentric Clinical Trial in Mexican Population
RandomizedParallel-groupTriple-blindTreatment
Summary
A randomized multicentric parallel arms study involving the use of ketamine for treatment-resistant depression will be held at three national health provider clinics in the Mexican population. The purpose of this study is to determine whether clinical response seen in previous studies is replicable in this population.
Timeline
- Start
- 2013-09
- Primary completion
- 2016-05
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketamine | Small molecule | 0.5 mg/kg | Intravenous |